JP2011510085A5 - - Google Patents

Download PDF

Info

Publication number
JP2011510085A5
JP2011510085A5 JP2010544374A JP2010544374A JP2011510085A5 JP 2011510085 A5 JP2011510085 A5 JP 2011510085A5 JP 2010544374 A JP2010544374 A JP 2010544374A JP 2010544374 A JP2010544374 A JP 2010544374A JP 2011510085 A5 JP2011510085 A5 JP 2011510085A5
Authority
JP
Japan
Prior art keywords
phenyl
hydroxy
compound
following structure
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2010544374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011510085A (ja
Filing date
Publication date
Priority claimed from US12/353,290 external-priority patent/US7956051B2/en
Application filed filed Critical
Publication of JP2011510085A publication Critical patent/JP2011510085A/ja
Publication of JP2011510085A5 publication Critical patent/JP2011510085A5/ja
Abandoned legal-status Critical Current

Links

JP2010544374A 2008-01-24 2009-01-15 緑内障治療におけるヒドラジン類 Abandoned JP2011510085A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2336508P 2008-01-24 2008-01-24
US12/353,290 US7956051B2 (en) 2008-01-24 2009-01-14 Therapeutic amides and related compounds
PCT/US2009/031081 WO2009094286A1 (en) 2008-01-24 2009-01-15 Hydrazines in glaucoma therapy

Publications (2)

Publication Number Publication Date
JP2011510085A JP2011510085A (ja) 2011-03-31
JP2011510085A5 true JP2011510085A5 (enExample) 2012-03-08

Family

ID=40899866

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010544374A Abandoned JP2011510085A (ja) 2008-01-24 2009-01-15 緑内障治療におけるヒドラジン類

Country Status (7)

Country Link
US (1) US7956051B2 (enExample)
EP (1) EP2247583A1 (enExample)
JP (1) JP2011510085A (enExample)
AU (1) AU2009206587A1 (enExample)
BR (1) BRPI0906661A2 (enExample)
CA (1) CA2712741A1 (enExample)
WO (1) WO2009094286A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014032735A1 (en) * 2012-09-03 2014-03-06 Grindeks Use of 3-(2,2,2-trimethylhydrazinium)-ethylpropionate or a pharmaceutically acceptable salt for treating high tension glaucoma

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
PT674516E (pt) 1992-12-16 2000-05-31 Agouron Pharma Compostos de 5-tiapirimidinona e 5-selenopirimidinona substituidos antiproliferativos
US5462968A (en) 1994-01-19 1995-10-31 Allergan, Inc. EP2 -receptor agonists as agents for lowering intraocular pressure
US5698598A (en) 1995-08-04 1997-12-16 Allergan EP2 -receptor agonists as agents for lowering intraocular pressure
US6090847A (en) 1997-11-21 2000-07-18 Allergan Sales, Inc. EP2 -receptor agonists as neuroprotective agents for the eye
US6437146B1 (en) 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
BR0213911A (pt) 2001-11-05 2004-09-28 Allergan Inc Análogos de Èmega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas do receptor ep2
US8148426B2 (en) 2004-11-19 2012-04-03 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amides) for increasing Hsp70 expression
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
WO2006121822A1 (en) * 2005-05-06 2006-11-16 Allergan, Inc. USE OF β-LACTAMS FOR THE TREATMENTOF IBD AND GLAUCOMA
FR2887879B1 (fr) 2005-07-01 2008-09-26 Trophos Sa Nouveaux composes chimiques et leurs utilisations comme medicament,particulierement dans le traitement des maladies neurodegeneratives
WO2007008942A2 (en) 2005-07-11 2007-01-18 Aerie Pharmaceuticals, Inc. Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
DE102006005179A1 (de) 2006-02-06 2007-08-09 Merck Patent Gmbh Aminoindazolderivate
JP2010500976A (ja) 2006-08-09 2010-01-14 アラーガン インコーポレイテッド 治療用アミド類および関連化合物

Similar Documents

Publication Publication Date Title
JP2010516778A5 (enExample)
CA2660608A1 (en) Therapeutic lactams
CN1340053A (zh) 依泊昔酮衍生物、其制备方法及药物用途
JP2011510085A5 (enExample)
CA2652866A1 (en) Therapeutic compounds
CA2724467A1 (en) Therapeutic lactams
AU2007267620B2 (en) Therapeutic pyrrolidine compounds
AU2007286135B2 (en) N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors
EP2331521B1 (en) Compounds for growing hair
AU2007286756B2 (en) Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
US8440819B2 (en) Therapeutic substituted beta-lactams
AU2009244539B2 (en) Therapeutic substituted hydantoins, and related compounds
AU2009223435B9 (en) Therapeutic compounds
CA2728229A1 (en) Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
US20150274658A1 (en) Therapeutic lactams
CA2723893A1 (en) Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives